カテゴリ： 世界, 医療/バイオ, Market Monitor Global

豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン

■ 英語タイトル：Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16194）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16194
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模と予測を収録しています。・世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル主要企業は、CAVAC、 Green Cross Veterinary Products、 Harrisvaccines、 Komipharm、 Nisseiken、 Qilu Animal Health、 Zoetis、 Wuhan Keqian、 China Animal Husbandry Industry、 Luoyang Huizhong、 Shanghai Hile Bio-Technology、 Harbin Weike、 Harbin Pharmaceutical Group、 Jiangsu Nannongなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：タイプ別市場シェア、2022年
・生ワクチン、不活化ワクチン

世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：用途別市場シェア、2022年
・子豚、成豚

世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル売上、2018年-2023年
・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル売上シェア、2022年
・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル販売量、2018年-2023年
・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
CAVAC、 Green Cross Veterinary Products、 Harrisvaccines、 Komipharm、 Nisseiken、 Qilu Animal Health、 Zoetis、 Wuhan Keqian、 China Animal Husbandry Industry、 Luoyang Huizhong、 Shanghai Hile Bio-Technology、 Harbin Weike、 Harbin Pharmaceutical Group、 Jiangsu Nannong

*************************************************************

・調査・分析レポートの概要
豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場の定義
市場セグメント
世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模
世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模：2022年 VS 2029年
世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの豚伝染性胃腸炎＆流行性下痢用デュアルワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：生ワクチン、不活化ワクチン
豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：子豚、成豚
豚伝染性胃腸炎＆流行性下痢用デュアルワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模 2022年と2029年
地域別豚伝染性胃腸炎＆流行性下痢用デュアルワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
CAVAC、 Green Cross Veterinary Products、 Harrisvaccines、 Komipharm、 Nisseiken、 Qilu Animal Health、 Zoetis、 Wuhan Keqian、 China Animal Husbandry Industry、 Luoyang Huizhong、 Shanghai Hile Bio-Technology、 Harbin Weike、 Harbin Pharmaceutical Group、 Jiangsu Nannong
...

This research report provides a comprehensive analysis of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market presents opportunities for various stakeholders, including Piglet, Adult Pig. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market.
Market Overview: The report provides a comprehensive overview of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Live Vaccine, Inactivated Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Live Vaccine
Inactivated Vaccine
Market segment by Application
Piglet
Adult Pig
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Wuhan Keqian
China Animal Husbandry Industry
Luoyang Huizhong
Shanghai Hile Bio-Technology
Harbin Weike
Harbin Pharmaceutical Group
Jiangsu Nannong
Outline of Major Chapters:
Chapter 1: Introduces the definition of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, market overview.
Chapter 2: Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Overall Market Size
2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size: 2022 VS 2029
2.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players in Global Market
3.2 Top Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies Ranked by Revenue
3.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Companies
3.4 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Companies
3.5 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Vaccine
4.1.3 Inactivated Vaccine
4.2 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue & Forecasts
4.2.1 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales & Forecasts
4.3.1 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2023
4.3.2 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2024-2029
4.3.3 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2022 & 2029
5.1.2 Piglet
5.1.3 Adult Pig
5.2 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue & Forecasts
5.2.1 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales & Forecasts
5.3.1 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2023
5.3.2 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2024-2029
5.3.3 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue & Forecasts
6.2.1 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales & Forecasts
6.3.1 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2023
6.3.2 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2024-2029
6.3.3 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.4.3 US Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.4.4 Canada Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.4.5 Mexico Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.5.3 Germany Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.4 France Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.5 U.K. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.6 Italy Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.7 Russia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.9 Benelux Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.6.3 China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.4 Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.5 South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.7 India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.7.3 Brazil Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.7.4 Argentina Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.8.3 Turkey Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8.4 Israel Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8.6 UAE Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CAVAC
7.1.1 CAVAC Company Summary
7.1.2 CAVAC Business Overview
7.1.3 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.1.4 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CAVAC Key News & Latest Developments
7.2 Green Cross Veterinary Products
7.2.1 Green Cross Veterinary Products Company Summary
7.2.2 Green Cross Veterinary Products Business Overview
7.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.2.4 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Green Cross Veterinary Products Key News & Latest Developments
7.3 Harrisvaccines
7.3.1 Harrisvaccines Company Summary
7.3.2 Harrisvaccines Business Overview
7.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.3.4 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Harrisvaccines Key News & Latest Developments
7.4 Komipharm
7.4.1 Komipharm Company Summary
7.4.2 Komipharm Business Overview
7.4.3 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.4.4 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Komipharm Key News & Latest Developments
7.5 Nisseiken
7.5.1 Nisseiken Company Summary
7.5.2 Nisseiken Business Overview
7.5.3 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.5.4 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Nisseiken Key News & Latest Developments
7.6 Qilu Animal Health
7.6.1 Qilu Animal Health Company Summary
7.6.2 Qilu Animal Health Business Overview
7.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.6.4 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Qilu Animal Health Key News & Latest Developments
7.7 Zoetis
7.7.1 Zoetis Company Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.7.4 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Zoetis Key News & Latest Developments
7.8 Wuhan Keqian
7.8.1 Wuhan Keqian Company Summary
7.8.2 Wuhan Keqian Business Overview
7.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.8.4 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Wuhan Keqian Key News & Latest Developments
7.9 China Animal Husbandry Industry
7.9.1 China Animal Husbandry Industry Company Summary
7.9.2 China Animal Husbandry Industry Business Overview
7.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.9.4 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 China Animal Husbandry Industry Key News & Latest Developments
7.10 Luoyang Huizhong
7.10.1 Luoyang Huizhong Company Summary
7.10.2 Luoyang Huizhong Business Overview
7.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.10.4 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Luoyang Huizhong Key News & Latest Developments
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Company Summary
7.11.2 Shanghai Hile Bio-Technology Business Overview
7.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.11.4 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Shanghai Hile Bio-Technology Key News & Latest Developments
7.12 Harbin Weike
7.12.1 Harbin Weike Company Summary
7.12.2 Harbin Weike Business Overview
7.12.3 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.12.4 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Harbin Weike Key News & Latest Developments
7.13 Harbin Pharmaceutical Group
7.13.1 Harbin Pharmaceutical Group Company Summary
7.13.2 Harbin Pharmaceutical Group Business Overview
7.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.13.4 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.14 Jiangsu Nannong
7.14.1 Jiangsu Nannong Company Summary
7.14.2 Jiangsu Nannong Business Overview
7.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.14.4 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Jiangsu Nannong Key News & Latest Developments
8 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity, Analysis
8.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity, 2018-2029
8.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Supply Chain Analysis
10.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Value Chain
10.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Upstream Market
10.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in Global Market
Table 2. Top Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Type
Table 9. List of Global Tier 1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, (K Units), 2024-2029
Table 46. CAVAC Company Summary
Table 47. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 48. CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. CAVAC Key News & Latest Developments
Table 50. Green Cross Veterinary Products Company Summary
Table 51. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 52. Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Green Cross Veterinary Products Key News & Latest Developments
Table 54. Harrisvaccines Company Summary
Table 55. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 56. Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Harrisvaccines Key News & Latest Developments
Table 58. Komipharm Company Summary
Table 59. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 60. Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Komipharm Key News & Latest Developments
Table 62. Nisseiken Company Summary
Table 63. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 64. Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Nisseiken Key News & Latest Developments
Table 66. Qilu Animal Health Company Summary
Table 67. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 68. Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Qilu Animal Health Key News & Latest Developments
Table 70. Zoetis Company Summary
Table 71. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 72. Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Zoetis Key News & Latest Developments
Table 74. Wuhan Keqian Company Summary
Table 75. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 76. Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Wuhan Keqian Key News & Latest Developments
Table 78. China Animal Husbandry Industry Company Summary
Table 79. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 80. China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. China Animal Husbandry Industry Key News & Latest Developments
Table 82. Luoyang Huizhong Company Summary
Table 83. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 84. Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Luoyang Huizhong Key News & Latest Developments
Table 86. Shanghai Hile Bio-Technology Company Summary
Table 87. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 88. Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Shanghai Hile Bio-Technology Key News & Latest Developments
Table 90. Harbin Weike Company Summary
Table 91. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 92. Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Harbin Weike Key News & Latest Developments
Table 94. Harbin Pharmaceutical Group Company Summary
Table 95. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 96. Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Harbin Pharmaceutical Group Key News & Latest Developments
Table 98. Jiangsu Nannong Company Summary
Table 99. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Offerings
Table 100. Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Jiangsu Nannong Key News & Latest Developments
Table 102. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region, 2018-2023 (K Units)
Table 105. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region, 2024-2029 (K Units)
Table 106. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Opportunities & Trends in Global Market
Table 107. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Drivers in Global Market
Table 108. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Restraints in Global Market
Table 109. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Raw Materials
Table 110. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Raw Materials Suppliers in Global Market
Table 111. Typical Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Downstream
Table 112. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Downstream Clients in Global Market
Table 113. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Segment by Type in 2022
Figure 2. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Segment by Application in 2022
Figure 3. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue in 2022
Figure 9. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 23. US Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 37. China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine by Region, 2022 VS 2029
Figure 54. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 鶏ニューカッスル病ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン
  • 鶏用ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン、
  • 豚生殖呼吸器症候群（PRRS）ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン
  • 日本脳炎ウイルスワクチンのグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン
  • ヒト用ワクチン接種のグローバル市場展望 2023年-2029年：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16194 )"豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル市場展望 2023年-2029年：生ワクチン、不活化ワクチン" (英文：Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。